IN2014MU00328A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00328A
IN2014MU00328A IN328MU2014A IN2014MU00328A IN 2014MU00328 A IN2014MU00328 A IN 2014MU00328A IN 328MU2014 A IN328MU2014 A IN 328MU2014A IN 2014MU00328 A IN2014MU00328 A IN 2014MU00328A
Authority
IN
India
Prior art keywords
drug
dissolution
nanocrystal
bioavailability
crystallized
Prior art date
Application number
Other languages
English (en)
Inventor
Kumar Guntamukkala Santosh
Satyanarayan Pattnaik
Kalpana Swain
Venkateshwar Rao Jupally
Baikuntha Prusty Korada
Sanjeev Kumar Subudhi
Original Assignee
Kumar Guntamukkala Santosh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kumar Guntamukkala Santosh filed Critical Kumar Guntamukkala Santosh
Priority to IN328MU2014 priority Critical patent/IN2014MU00328A/en
Publication of IN2014MU00328A publication Critical patent/IN2014MU00328A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN328MU2014 2014-01-30 2014-01-30 IN2014MU00328A (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN328MU2014 IN2014MU00328A (https=) 2014-01-30 2014-01-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN328MU2014 IN2014MU00328A (https=) 2014-01-30 2014-01-30

Publications (1)

Publication Number Publication Date
IN2014MU00328A true IN2014MU00328A (https=) 2015-09-11

Family

ID=54393678

Family Applications (1)

Application Number Title Priority Date Filing Date
IN328MU2014 IN2014MU00328A (https=) 2014-01-30 2014-01-30

Country Status (1)

Country Link
IN (1) IN2014MU00328A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021008652A1 (de) * 2019-07-15 2021-01-21 MyBiotech GmbH Nanostrukturierte ibuprofen-zusammensetzungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021008652A1 (de) * 2019-07-15 2021-01-21 MyBiotech GmbH Nanostrukturierte ibuprofen-zusammensetzungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzung

Similar Documents

Publication Publication Date Title
PH12017502155A1 (en) Formation of cyclosporin a/cyclodextrin nanoparticles
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
MX370853B (es) Formulaciones que contienen dapagliflozina amorfa.
PH12016502378A1 (en) Substituted dihydroisoquinolinone compounds
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
MX2016005668A (es) Formas cristalinas de compuestos terapeuticos y sus usos.
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
NZ704092A (en) Ph adjusted pulse protein product
WO2016011049A3 (en) Compositions and methods for disease treatment using nanoparticle delivered compounds
WO2014131422A3 (en) Fermented rapeseed feed ingredient
MX2016007316A (es) Prevencion de infecciones por staphylococcus aureus mediante vacunas de glucoproteina sintetizadas en escherichia coli.
MY190283A (en) Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
NZ735736A (en) Acetate salt of buprenorphine and methods for preparing buprenorphine
SMT202200275T1 (it) Nanoparticelle quali veicoli di rilascio di principi attivi e metodi per la loro produzione
SG10201909412RA (en) Composition for suppressing muscular fatty change
SG10201902499VA (en) Therapeutic nanoparticles and related compositions, methods and systems
PH12015502820A1 (en) Nanoparticulate formulation comprising a trpa1 antagonist
IN2014MU00328A (https=)
MX2017002790A (es) Sal de un derivado de cefalosporina, forma solida cristalina del mismo y metodo para su produccion.
IN2013MU03610A (https=)
WO2015074667A3 (en) Composition for dermatitis
NZ724063A (en) Pyrazine derivatives having pharmaceutical activity
NZ728136A (en) Method for producing aqueous ophthalmic composition, and aqueous ophthalmic composition
Kamarudin et al. Effect of Gold Nanoparticles Structural Variations on Mercury Removal
PL407710A1 (pl) Sposób wytwarzania preparatu kropli do oczu w postaci zawiesiny zawierającej brynzolamid i preparat wytworzony tym sposobem